Results 231 to 240 of about 10,355,590 (280)

Exploring the Utility of Cell-Free DNA Hydroxymethylation Profiling in Small-Cell Lung Cancer. [PDF]

Int J Mol Sci
Li JJN, Cheng D, Zhan LJ, Sacdalan DB, Ul Haq S, Singhawansa A, Philip V, Leighl NB, Bratman SV, Liu G, Lok BH.   +10 more
europepmc   +1 more source

Diagnostic Test Accuracy of Detecting Donor-Derived Cell-Free DNA in Renal Transplant Rejection: A Systematic Review and Meta-Analysis. [PDF]

J Transplant
Wong CS, Tryliskyy Y, Rashid R, Barman S, Shuymeko V, Sharma A, Hossain M.   +6 more
europepmc   +1 more source

Cancer-Like Fragmentomic Characteristics of Somatic Variants in Cell-Free DNA. [PDF]

Adv Sci (Weinh)
Zhang Z, An Y, Yang M, Pan Y, Liu X, Gong F, Lin H, Tang B, Bai Y, Zhao X, Zhao Y, Du C, Sun K.   +12 more
europepmc   +1 more source

Diagnostic performance of donor-derived cell-free DNA for acute rejection in kidney allograft biopsies. [PDF]

J Bras Nefrol
Nakamura MR, Foresto RD, Gomes VRDS, Proença HM, Requião-Moura L, Medina-Pestana J, Tedesco-Silva H.   +6 more
europepmc   +1 more source

First-trimester multi-modal cell-free DNA analysis for prediction of preterm and term preeclampsia. [PDF]

AJOG Glob Rep
Ertl R, Syngelaki A, Frank O, Lüftinger L, Lukáčová E, Lumby C, Stütz A, Beisken S, Posch AE, Nicolaides KH.   +9 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Cell-free DNA

Anais do 6º Simpósio de Saúde: Saúde 4.0 - Tecnologia e Inovação, 2023
O DNA livre de células, ou cfDNA, tem sido cada vez mais reconhecido como um biomarcador importante em diversas áreas da medicina.
Diogo Barcelos Almeida, Bárbara Stefanie de Souza Scodeler, Kelly Dos Santos Gonçalves, Maria Júlia Sá, Leiridiane Martins, Gabrielle Alves de Paiva, André Luís Braghini Sá   +6 more
openaire   +2 more sources

Cell-Free DNA in Rheumatoid Arthritis [PDF]

International Journal of Molecular Sciences, 2021
Endogenous DNA derived from the nuclei or mitochondria is released into the bloodstream following cell damage or death. Extracellular DNA, called cell-free DNA (cfDNA), is associated with various pathological conditions. Recently, multiple aspects of cfDNA have been assessed, including cfDNA levels, integrity, methylation, and mutations.
Teppei Hashimoto, Kohsuke Yoshida, Akira Hashiramoto   +2 more
exaly   +3 more sources

Cell-Free DNA in Dermatology Research

Journal of Investigative Dermatology, 2022
In various diseases, particularly cancer, cell-free DNA (cfDNA) has been widely studied as a marker of disease prognosis or to facilitate the detection of therapeutic targets. In dermatology, most studies have focused on melanoma; other skin diseases such as vascular malformations and psoriasis have also been examined. Genetic alterations unique to the
Jennifer M. Wiggins, Saim Ali, David Polsky   +2 more
openaire   +2 more sources

Adipose cell-free DNA in diabetes

Clinica Chimica Acta, 2023
Cancer-associated necrosis is a well-known source of cell-free DNA (cfDNA). However, the origins of cfDNA are not strictly limited to cancer. Additionally, dietary exposure induces apoptosis-induced proliferation in adipocytes, leading to the release of cfDNA.
Humardani, Farizky Martriano, Mulyanata, Lisa Thalia, Putra, Sulistyo Emantoko Dwi   +2 more
openaire   +3 more sources

Cell-free DNA: Preanalytical variables

Clinica Chimica Acta, 2015
Since the discovery of cell-free DNA (cfDNA) in human blood, most studies have focused on diagnostic and prognostic uses of these markers for solid tumors. Except for some prenatal tests and BEAMing, cfDNA analysis has not yet been translated to clinical practice and routine application appears distant. This can be attributed to overlapping factors: (i)
Abel Jacobus Bronkhorst, Janine Aucamp, Piet J. Pretorius   +2 more
openaire   +3 more sources